83 related articles for article (PubMed ID: 20551045)
21. Injection drug use, HIV and the current response in selected low-income and middle-income countries.
Bergenstrom AM; Abdul-Quader AS
AIDS; 2010 Sep; 24 Suppl 3():S20-9. PubMed ID: 20926924
[TBL] [Abstract][Full Text] [Related]
22. HIV and HCV infection among injecting drug users.
Hagan H; Des Jarlais DC
Mt Sinai J Med; 2000; 67(5-6):423-8. PubMed ID: 11064493
[TBL] [Abstract][Full Text] [Related]
23. HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.
Talu A; Rajaleid K; Abel-Ollo K; Rüütel K; Rahu M; Rhodes T; Platt L; Bobrova N; Uusküla A
Int J Drug Policy; 2010 Jan; 21(1):56-63. PubMed ID: 19395249
[TBL] [Abstract][Full Text] [Related]
24. Medical management of HIV-hepatitis C virus coinfection in injection drug users.
Khalsa JH; Kresina T; Sherman K; Vocci F
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S1-6. PubMed ID: 16265605
[TBL] [Abstract][Full Text] [Related]
25. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
[TBL] [Abstract][Full Text] [Related]
26. First injection and current risk factors for HIV among new and long-term injection drug users.
Chitwood DD; Sanchez J; Comerford M; Page JB; McBride DC; Kitner KR
AIDS Care; 2000 Jun; 12(3):313-20. PubMed ID: 10928209
[TBL] [Abstract][Full Text] [Related]
27. Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors.
De La Fuente L; Bravo MJ; Barrio G; Parras F; Suárez M; Rodés A; Noguer I
Clin Infect Dis; 2003 Dec; 37 Suppl 5():S410-5. PubMed ID: 14648456
[TBL] [Abstract][Full Text] [Related]
28. Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study.
Lindenburg CE; Krol A; Smit C; Buster MC; Coutinho RA; Prins M
AIDS; 2006 Aug; 20(13):1771-5. PubMed ID: 16931942
[TBL] [Abstract][Full Text] [Related]
29. An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. WHO Collaborative Study Group.
Bull Narc; 1993; 45(1):19-46. PubMed ID: 8305904
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
[TBL] [Abstract][Full Text] [Related]
31. Estimating the population prevalence of injection drug use and infection with human immunodeficiency virus among injection drug users in Glasgow, Scotland.
Frischer M; Leyland A; Cormack R; Goldberg DJ; Bloor M; Green ST; Taylor A; Covell R; McKeganey N; Platt S
Am J Epidemiol; 1993 Aug; 138(3):170-81. PubMed ID: 8356960
[TBL] [Abstract][Full Text] [Related]
32. Estimates of HIV infection among injecting drug users in Glasgow, 1985-1990.
Frischer M; Green ST; Goldberg DJ; Haw S; Bloor M; McKeganey N; Covell R; Taylor A; Gruer LD; Kennedy D
AIDS; 1992 Nov; 6(11):1371-5. PubMed ID: 1472341
[TBL] [Abstract][Full Text] [Related]
33. HIV prevalence no higher among female drug injectors also involved in prostitution.
Rhodes T; Donoghoe M; Hunter G; Stimson GV
AIDS Care; 1994; 6(3):269-76. PubMed ID: 7948083
[TBL] [Abstract][Full Text] [Related]
34. HIV among injection drug users in large US metropolitan areas, 1998.
Friedman SR; Lieb S; Tempalski B; Cooper H; Keem M; Friedman R; Flom PL
J Urban Health; 2005 Sep; 82(3):434-45. PubMed ID: 16014877
[TBL] [Abstract][Full Text] [Related]
35. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users.
Friedman SR; Tempalski B; Cooper H; Perlis T; Keem M; Friedman R; Flom PL
J Urban Health; 2004 Sep; 81(3):377-400. PubMed ID: 15273263
[TBL] [Abstract][Full Text] [Related]
36. Estimating the number of people living with HIV and the undiagnosed fraction in Spain in 2013.
Nuñez O; Hernando V; Díaz A
AIDS; 2018 Nov; 32(17):2573-2581. PubMed ID: 30096075
[TBL] [Abstract][Full Text] [Related]
37. A Bayesian approach to synthesize estimates of the size of hidden populations: the Anchored Multiplier.
Wesson PD; Mirzazadeh A; McFarland W
Int J Epidemiol; 2018 Oct; 47(5):1636-1644. PubMed ID: 29931067
[TBL] [Abstract][Full Text] [Related]
38. [Estimating mortality attributed to illegal drug use in Spain].
Brugal MT; Barrio G; Royuela L; Bravo MJ; de la Fuente L; Regidor E
Med Clin (Barc); 2004 Dec; 123(20):775-7. PubMed ID: 15607069
[TBL] [Abstract][Full Text] [Related]
39. A method to estimate total entry to hard drug use: the case of intravenous drug use in Norway.
Amundsen EJ; Bretteville-Jensen AL; Kraus L
Eur Addict Res; 2011; 17(3):129-35. PubMed ID: 21358202
[TBL] [Abstract][Full Text] [Related]
40. Assessing network scale-up estimates for groups most at risk of HIV/AIDS: evidence from a multiple-method study of heavy drug users in Curitiba, Brazil.
Salganik MJ; Fazito D; Bertoni N; Abdo AH; Mello MB; Bastos FI
Am J Epidemiol; 2011 Nov; 174(10):1190-6. PubMed ID: 22003188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
